+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Behcet's Disease Therapeutics Market 2024-2028 - Product Thumbnail Image

Behcet's Disease Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 149 Pages
  • Global
From
Uveitis Drugs Market 2024-2028 - Product Thumbnail Image

Uveitis Drugs Market 2024-2028

  • Report
  • August 2024
  • 143 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
From
Market Spotlight: Psoriatic Arthritis - Product Thumbnail Image

Market Spotlight: Psoriatic Arthritis

  • Report
  • September 2020
  • 65 Pages
  • Global
From
Axial Spondyloarthritis Market - Global Forecast to 2030 - Product Thumbnail Image

Axial Spondyloarthritis Market - Global Forecast to 2030

  • Report
  • May 2025
  • 186 Pages
  • Global
From
From
Type 2 Diabetes Market Report 2025 - Product Thumbnail Image

Type 2 Diabetes Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator